Publication | Closed Access

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study

Hematological MalignancyMixed-phenotype Acute LeukemiaBcr-abl Peptide ImmunisationHematologyImmunologyPathologyEpic StudyAutoimmunityClinical EvaluationImmunotherapyMedicineMyelopoiesisMyeloid Neoplasia